Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Sancho, D., Joffre, O.P., Keller, A.M., Rogers, N.C., Martinez, D., Hernanz-Falcon, P.,
Rosewell, I., and Reis e Sousa, C. (2009). Identification of a dendritic cell receptor that
couples sensing of necrosis to immunity. Nature 458, 899-903.
Santini, S.M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., and
Belardelli, F. (2000). Type I interferon as a powerful adjuvant for monocyte-derived dendritic
cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191, 1777-
1788.
Savina, A., and Amigorena, S. (2007). Phagocytosis and antigen presentation in dendritic
cells. Immunol Rev 219, 143-156.
Savina, A., Jancic, C., Hugues, S., Guermonprez, P., Vargas, P., Moura, I.C., Lennon-
Dumenil, A.M., Seabra, M.C., Raposo, G., and Amigorena, S. (2006). NOX2 controls
phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells.
Cell 126, 205-218.
Schepers, K., Swart, E., van Heijst, J.W., Gerlach, C., Castrucci, M., Sie, D., Heimerikx, M.,
Velds, A., Kerkhoven, R.M., Arens, R., et al. (2008). Dissecting T cell lineage relationships
by cellular barcoding. J Exp Med 205, 2309-2318.
Schilte, C., Couderc, T., Chretien, F., Sourisseau, M., Gangneux, N., Guivel-Benhassine, F.,
Kraxner, A., Tschopp, J., Higgs, S., Michault, A., et al. (2010). Type I IFN controls
chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207, 429-442.
Schlom, J., Arlen, P.M., and Gulley, J.L. (2007). Cancer vaccines: moving beyond current
paradigms. Clin Cancer Res 13, 3776-3782.
Schmidt, C. (2007). Clinical setbacks for toll-like receptor 9 agonists in cancer. Nat
Biotechnol 25, 825-826.
Schmidt, C.S., and Mescher, M.F. (1999). Adjuvant effect of IL-12: conversion of peptide
antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. J Immunol
163, 2561-2567.
Schmidt, J., Neumann-Haefelin, C., Altay, T., Gostick, E., Price, D.A., Lohmann, V., Blum,
H.E., and Thimme, R. (2011). Immunodominance of HLA-A2-restricted hepatitis C virusspecific
CD8+ T cell responses is linked to naive-precursor frequency. J Virol 85, 5232-5236.
Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832.
Schulz, O., Diebold, S.S., Chen, M., Naslund, T.I., Nolte, M.A., Alexopoulou, L., Azuma,
Y.T., Flavell, R.A., Liljestrom, P., and Reis e Sousa, C. (2005). Toll-like receptor 3 promotes
cross-priming to virus-infected cells. Nature 433, 887-892.
Schulze, D.H., Pease, L.R., Geier, S.S., Reyes, A.A., Sarmiento, L.A., Wallace, R.B., and
Nathenson, S.G. (1983). Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb
gene shows a cluster of seven nucleotide differences. Proc Natl Acad Sci U S A 80, 2007-
2011.
Schumacher, T.N., Gerlach, C., and van Heijst, J.W. (2010). Mapping the life histories of T
cells. Nat Rev Immunol 10, 621-631.
Schwarz, K., Storni, T., Manolova, V., Didierlaurent, A., Sirard, J.C., Rothlisberger, P., and
Bachmann, M.F. (2003). Role of Toll-like receptors in costimulating cytotoxic T cell
responses. Eur J Immunol 33, 1465-1470.
Seder, R.A., Darrah, P.A., and Roederer, M. (2008). T-cell quality in memory and protection:
implications for vaccine design. Nat Rev Immunol 8, 247-258.
250